-
AI for Pricing Reimbursement: When to Green-Light, When to Red-Light?
Sep 9, 2025, 16:22 PM -
Utility Values From Pooled Analysis of High Concentration (179 mg) Capsaicin Patch (HCCP) Studies In Peripheral Neuropathic Pain (PNP)
Sep 9, 2025, 16:22 PM -
Recent Changes in HTA and Reimbursement Requirements: Learnings for Global Dossiers
Sep 9, 2025, 16:22 PM -
Evaluating Digital Health Tools in the UK for Type 1/2 Diabetes: An Overview of the Evidence Critiques
Sep 9, 2025, 16:22 PM -
Group A Streptococcal Infections—Diagnostic Approaches and Antibiotics Prescriptions in Children and Adolescents in Germany: A Nationwide Representative Claims Data Analysis
Sep 9, 2025, 16:22 PM -
A Nutrient-Dense Formula in Undernourished Children in Indonesia: An Effective Cost-Saving Strategy
Sep 9, 2025, 16:22 PM -
Impact of SGLT2-Inhibitor Uptake in CKD Management in Denmark: A Decision Economic Model
Sep 9, 2025, 16:22 PM -
Exploring the Impact of Dupilimab on the Patient Care Pathways: GHG Emissions of Patients With Moderate-to-Severe COPD In France
Sep 9, 2025, 16:22 PM -
Screening and Diagnosis of Paroxysmal Nocturnal Hemoglobinuria in Greece: Consensus Recommendations From a Multispecialty Expert Panel
Sep 9, 2025, 16:22 PM -
Fostamatinib-Induced Hepatomegaly: A Novel Signal Identified Through US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of RefluxStop for Treatment of Chronic Gastro-esophageal Reflux Disease: A US Medicare Perspective
Sep 9, 2025, 16:22 PM -
Evaluating the Value Elements Considered in Health Technology Assessments of Paroxysmal Nocturnal Hemoglobinuria Treatments: A Targeted Review
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis (CUA) of Sepiapterin for Treatment of Phenylketonuria (PKU)
Sep 9, 2025, 16:22 PM -
Real-World Data for External Controls: Insights From EMA Regulatory Submissions
Sep 9, 2025, 16:22 PM -
Quo Vadis? The Emerging Role of the Medicines and Healthcare Products Regulatory Agency (MHRA) in an Evolving Regulatory Landscape
Sep 9, 2025, 16:22 PM -
Activity of the French Economic and Public Health Evaluation Committee (CEESP): Retrospective of 10 Years of Economic Assessment on Health Products
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Patient-Reported Outcomes (PROs) in Asthma Biologic Late-Phase Studies and Approved Labels: Implications for Entry and Product Differentiation
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Evaluation of Blinatumomab Use in the Measurable Residual Disease-Negative Remission State to Treat Adults With Philadelphia-Chromosome–Negative B-cell Acute Lymphoblastic Leukemia in France
Sep 9, 2025, 16:22 PM -
Influencing Factors on the Health-Related Quality of Life of Middle-Aged and Elderly People in Ethnic Minority Areas of China: An Analysis Based on the Survey in a Urban Community of Guangxi Province
Sep 9, 2025, 16:22 PM -
Financial Impact of Dementia Care on Thai Households: A Multicenter Study of Informal Care Costs and Contributing Factors
Sep 9, 2025, 16:22 PM
